Home › Funds › Two Sigma Investments › CYPH
Two Sigma Investments position in CYPH
LEAP THERAPEUTICS INC · Health Care
Latest position (Q2 2026)80.41K sh
Reported value held$49.24K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 23.32K | $45.72K | New |
| Q1 2025 | 12.84K | $3.92K | New |
| Q2 2025 | 13.90K | $4.13K | Add |
| Q3 2025 | 70.85K | $32.16K | Add |
| Q4 2025 | 72.17K | $83.72K | Add |
| Q1 2026 | 66.57K | $52.90K | Reduce |
| Q2 2026 | 80.41K | $49.24K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CYPH
- Vanguard Group 2.13M sh · $2.47M · Q4 2025
- BlackRock Inc 2.62M sh · $1.61M · Q2 2026
- Citadel Advisors 1.29M sh · $787.70K · Q2 2026
- Geode Capital Management 1.17M sh · $718.80K · Q2 2026
- UBS Group AG 1.13M sh · $689.95K · Q2 2026
- Northern Trust Corp 222.03K sh · $135.95K · Q2 2026
- Morgan Stanley 174.59K sh · $106.90K · Q2 2026
- JPMorgan Chase & Co 227 sh · $144 · Q2 2026
- Fidelity Management & Research (FMR) 100 sh · $61 · Q2 2026